Changes in peripheral blood leukocyte profiles during elexacaftor/tezacaftor/ivacaftor therapy in cystic fibrosis according to baseline lung function
{{output}}
Background: Cystic fibrosis (CF) is a chronic genetic disease characterised by impaired ion transport, persistent airway inflammation and recurrent respiratory infections. The introduction of CFTR modulators, including elexacafto... ...
